{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:20:08Z","timestamp":1762431608010,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R03HS024810"],"award-info":[{"award-number":["R03HS024810"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.urology.2019.02.027","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T03:06:12Z","timestamp":1552878372000},"page":"87-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prospective Implementation of a Point-of-Care PCR-Based Detection Method to Guide Antibiotic Use Prior to Prostate Biopsy Compared to Targeted Prophylaxis and Physician Choice"],"prefix":"10.1016","volume":"129","author":[{"given":"Michael A.","family":"Liss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Sherrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Barney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Yunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evenki","family":"Sokurenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Wickes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2019.02.027_bib0001","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.02.027_bib0002","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","article-title":"The incidence of fluoroquinolone resistant infections after prostate biopsy\u2013are fluoroquinolones still effective prophylaxis?","volume":"179","author":"Feliciano","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.02.027_bib0003","first-page":"6573","article-title":"Variability of transrectal ultrasound-guided prostate biopsy prophylactic measures","volume":"19","author":"Hillelsohn","year":"2012","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2019.02.027_bib0004","doi-asserted-by":"crossref","first-page":"212","DOI":"10.47102\/annals-acadmedsg.V38N3p212","article-title":"Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy","volume":"38","author":"Ho","year":"2009","journal-title":"Ann Acad Med, Singapore"},{"key":"10.1016\/j.urology.2019.02.027_bib0005","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","article-title":"Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care","volume":"187","author":"Taylor","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.02.027_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.urpr.2014.10.011","article-title":"AUA quality improvement summit 2014: conference proceedings on infectious complications of transrectal prostate needle biopsy","volume":"2","author":"Averch","year":"2014","journal-title":"Urol Pract"},{"key":"10.1016\/j.urology.2019.02.027_bib0007","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.urology.2012.10.056","article-title":"Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy","volume":"81","author":"Liss","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.urology.2019.02.027_bib0008","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.urology.2015.07.008","article-title":"Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy","volume":"86","author":"Tchesnokova","year":"2015","journal-title":"Urology"},{"year":"2010","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement M100-S20","key":"10.1016\/j.urology.2019.02.027_bib0009"},{"key":"10.1016\/j.urology.2019.02.027_bib0010","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/JCM.00984-13","article-title":"Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome","volume":"51","author":"Tchesnokova","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.urology.2019.02.027_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2015.07.008","article-title":"Rapid identification of rectal multi-drug resistant E. coli prior to transrectal prostate biopsy","author":"Tchesnokova","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2019.02.027_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2018.02.528","article-title":"Targeted antimicrobial prophylaxis does not always prevent sepsis after transrectal prostate biopsy","author":"Jiang","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.02.027_bib0013","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.juro.2015.03.110","article-title":"Comparative effectiveness of targeted vs empirical antibiotic prophylaxis to prevent sepsis from transrectal prostate biopsy: a retrospective analysis","volume":"194","author":"Liss","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.02.027_bib0014","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/cid\/ciu1129","article-title":"Clinical and microbiological determinants of infection after transrectal prostate biopsy","volume":"60","author":"Liss","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urology.2019.02.027_bib0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jiac.2014.06.011","article-title":"Clinical effectiveness and safety of tazobactam\/piperacillin 4.5 g for the prevention of febrile infectious complication after prostate biopsy","volume":"20","author":"Yasuda","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.urology.2019.02.027_bib0016","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1056\/NEJMp1311479","article-title":"Preserving antibiotics, rationally","volume":"369","author":"Hollis","year":"2013","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.urology.2019.02.027_bib0017","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1007\/BF01793579","article-title":"Bacterial resistance to fluoroquinolones: lessons to be learned","volume":"22","author":"Ball","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.urology.2019.02.027_bib0018","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.juro.2015.03.126","article-title":"A statewide intervention to reduce hospitalizations after prostate biopsy","volume":"194","author":"Womble","year":"2015","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951930233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951930233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:58:57Z","timestamp":1758765537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951930233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":18,"alternative-id":["S009042951930233X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2019.02.027","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Implementation of a Point-of-Care PCR-Based Detection Method to Guide Antibiotic Use Prior to Prostate Biopsy Compared to Targeted Prophylaxis and Physician Choice","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2019.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}